無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

幹細胞の世界市場の予測

GLOBAL STEM CELL MARKET FORECAST 2018-2026

発行 Inkwood Research 商品コード 484190
出版日 ページ情報 英文 155 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
幹細胞の世界市場の予測 GLOBAL STEM CELL MARKET FORECAST 2018-2026
出版日: 2018年07月20日 ページ情報: 英文 155 Pages
概要

当レポートでは、幹細胞の世界市場について分析し、市場の基本的構造や市場成長への各種影響要因、市場動向と今後の見通し、製品・技術・用途・地域別の詳細な動向、競合情勢、市場発展の方向性、主要企業のプロファイルなどをまとめています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の決定要因

  • 成長促進要因
  • 成長阻害要因
  • 市場機会
  • 市場課題

第5章 幹細胞の世界市場:市場区分

  • 製品別
    • 成体幹細胞
    • ヒトES細胞
    • 人口多能性幹細胞
    • マウス神経細胞
  • 技術別
    • 幹細胞の獲得
      • 造血幹細胞(HSC)
      • 幹細胞アファレーシス
      • 臍帯血幹細胞
    • 幹細胞の生産
      • 治療的クローニング
      • 体外受精幹細胞
      • 幹細胞培養
    • 幹細胞の凍結保存
    • 幹細胞増殖と2次培養
  • 用途別
    • 幹細胞再生医療
    • 創薬・医薬品開発
  • 第6章 市場分析
  • ファイブフォース分析
  • PESTEL分析
  • バリューチェーン分析
  • 市場機会マトリクス
  • 購買基準
  • 戦略提言・結論
  • ベンダー概要

第7章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • 韓国
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・北アフリカ
    • アフリカ

第8章 競合環境

  • 市場シェア分析

第9章 企業プロファイル

目次
Product Code: 4685

KEY FINDINGS

The global stem cell market is anticipated to expand at a CAGR of 9.73% during the forecast period of 2018-2026. The rise in neurodegenerative diseases and heavy investments in adult stem cell research are factors that are contributing to the market growth in this region.

MARKET INSIGHTS

The global stem cell market is segmented on the basis of product, technology, application, and geography. The stem cell market on the basis of product is divided into an adult stem cell, human embryonic stem cell, induced pluripotent stem cell market and rat neural stem cell market. The stem cell market by technology is segmented into stem cell acquisition market, stem cell production market, stem cell cryopreservation market and stem cells expansion and sub-culture market. The application of the stem cell market is segmented into stem cells regenerative medicine market and drug discovery and development market. The stem cell market geography is segmented into North America, Europe, Asia-Pacific and rest of the world.

REGIONAL INSIGHTS

The Stem Cell market in North America is expected to hold the largest share by 2026. Increased investments in research and development activities for the stem cell market and the presence of popular pharmaceutical market have contributed to the growth of the US market in the North American region. Asia- Pacific is anticipated to grow with the fastest CAGR over the forecast period. The growth of the Asia-Pacific region is primarily driven by the growing incidences of chronic lifestyle diseases and government supports and their initiatives. On the other hand, the Europe stem cell analysis market is primarily driven by the rising prevalence of chronic disorders such as cancer and cardiovascular disorders.

COMPETITIVE INSIGHTS

The leading players in the stem cell market are Becton Dickinson, Biotime Inc, Brainstorm Cell Therapeutics, Celgene Corporation, Cellular Dynamics International (Holding Company Fujifilm), Cellular Engineering Technologies Inc, Corestem Inc, Corning Inc., Cytori Therapeutics, Fibrocell Science Inc, Ge Healthcare,Kangstem Biotech Ltd, Stemedica Cell Technologies Inc, Takara Holdings Inc., and Thermo Fisher Vericel Corporation (Formerly Aastrom Bioscience).

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION
  • 2.5. ESTIMATION METHODOLOGY

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REGENERATIVE MEDICINE IS THE EMERGING BRANCH OF MEDICAL SCIENCE
    • 3.2.2. USE OF ADULT STEM CELLS HAS BEEN SIGNIFICANT

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVER
    • 4.1.1. POTENTIAL OF STEM CELLS IN REGENERATIVE MEDICINE
    • 4.1.2. KEY TO ANTI-AGEING AND PROLONGING LIFE
    • 4.1.3. INCREASING R&D INVESTMENTS IN ADULT STEM CELL RESEARCH
    • 4.1.4. EASE OF ADMINISTRATION
    • 4.1.5. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • 4.1.6. FEDERAL FUNDING FOR STEM CELL RESEARCH
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. SAFETY ISSUES
    • 4.2.2. ETHICAL ISSUES
  • 4.3. OPPORTUNITIES
    • 4.3.1. TECHNOLOGICAL INNOVATIONS
    • 4.3.2. EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
    • 4.3.3. OTHER PROMISING APPLICATIONS
  • 4.4. MARKET CHALLENGES
    • 4.4.1. STRINGENT GOVERNMENT REGULATIONS
    • 4.4.2. LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY PRODUCTS 2018-2026
    • 5.1.1. ADULT STEM CELL MARKET
      • 5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
      • 5.1.1.2. MESENCHYMAL STEM CELL MARKET
      • 5.1.1.3. NEURAL STEM CELL MARKET
      • 5.1.1.4. DENTAL STEM CELL MARKET
      • 5.1.1.5. UMBILICAL CORD STEM CELL MARKET
    • 5.1.2. HUMAN EMBRYONIC STEM CELL
    • 5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
    • 5.1.4. RAT NEURAL STEM CELL MARKET
  • 5.2. MARKET BY TECHNOLOGY 2018-2026
    • 5.2.1. STEM CELL ACQUISITION
      • 5.2.1.1. STEM CELL BONE MARROW MARKET
      • 5.2.1.2. STEM CELL APHERESIS MARKET
      • 5.2.1.3. UMBILICAL CORD BLOOD MARKET
    • 5.2.2. STEM CELL PRODUCTION
      • 5.2.2.1. THERAPEUTIC CLONING
      • 5.2.2.2. IVF STEM CELL
      • 5.2.2.3. STEM CELL CULTURE
    • 5.2.3. STEM CELL CRYOPRESERVATION
    • 5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE
  • 5.3. MARKET BY APPLICATION 2018-2026
    • 5.3.1. REGENERATIVE MEDICINE
    • 5.3.2. DRUG DISCOVERY AND DEVELOPMENT

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 6.1.3. BARGAINING POWER OF BUYER
    • 6.1.4. BARGAINING POWER OF SUPPLIER
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. KEY BUYING CRITERIA
    • 6.4.1. HIGH PRICE
    • 6.4.2. EFFICACY
    • 6.4.3. APPLICATION AND EFFECTIVENESS
    • 6.4.4. ACCURACY
  • 6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
  • 6.6. PEST ANALYSIS
  • 6.7. HISTORY OF STEM CELL
  • 6.8. PATENT ANALYSIS
    • 6.8.1. STEM CELL PATENT IN NORTH AMERICA
    • 6.8.2. STEM CELL PATENT IN EUROPE
    • 6.8.3. STEM CELL PATENT IN ASIA PACIFIC
  • 6.9. REGULATORY FRAMEWORK

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. ITALY
    • 7.2.6. REST OF EUROPE
  • 7.3. ASIA PACIFIC (APAC)
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. SOUTH KOREA
    • 7.3.5. REST OF ASIA PACIFIC (ROAPAC)
  • 7.4. REST OF WORLD (ROW)
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA
    • 7.4.3. REST OF AFRICA

8. COMPANY PROFILE

  • 8.1. COMPETITIVE LANDSCAPE
    • 8.1.1. MARKET SHARE ANALYSIS
  • 8.2. BECTON DICKINSON
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SCOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. BIOTIME INC
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. SCOT ANALYSIS
    • 8.3.4. STRATEGIC INITIATIVES
  • 8.4. BRAINSTORM CELL THERAPEUTICS
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. SCOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. CELGENE CORPORATION
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SCOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. SCOT ANALYSIS
    • 8.6.4. STRATEGIC INITIATIVES
  • 8.7. CELLULAR ENGINEERING TECHNOLOGIES INC.
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. SCOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. CORESTEM INC
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. SCOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. CORNING INC.
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. CYTORI THERAPEUTICS
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SCOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES
  • 8.11. FIBROCELL SCIENCE INC
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SCOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVES
  • 8.12. GE HEALTHCARE
    • 8.12.1. COMPANY OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. SCOT ANALYSIS
    • 8.12.4. STRATEGIC INITIATIVES
  • 8.13. KANGSTEM BIOTECH LTD
    • 8.13.1. COMPANY OVERVIEW
    • 8.13.2. PRODUCT PORTFOLIO
    • 8.13.3. STRATEGIC INITIATIVES
  • 8.14. STEMEDICA CELL TECHNOLOGIES INC
    • 8.14.1. COMPANY OVERVIEW
    • 8.14.2. PRODUCT PORTFOLIO
    • 8.14.3. STRATEGIC INITIATIVES
  • 8.15. STRYKER CORPORATION
    • 8.15.1. COMPANY OVERVIEW
    • 8.15.2. PRODUCT PORTFOLIO
    • 8.15.3. SCOT ANALYSIS
    • 8.15.4. STRATEGIC INITIATIVES
  • 8.16. TAKARA HOLDINGS INC.
    • 8.16.1. COMPANY OVERVIEW
    • 8.16.2. PRODUCT PORTFOLIO
    • 8.16.3. SCOT ANALYSIS
    • 8.16.4. STRATEGIC INITIATIVES
  • 8.17. THERMO FISHER
    • 8.17.1. COMPANY OVERVIEW
    • 8.17.2. PRODUCT PORTFOLIO
    • 8.17.3. SCOT ANALYSIS
    • 8.17.4. STRATEGIC INITIATIVES
  • 8.18. VERICEL CORPORATION (FORMERLY AASTROM BIOSCIENCE)
    • 8.18.1. COMPANY OVERVIEW
    • 8.18.2. PRODUCT PORTFOLIO
    • 8.18.3. SCOT ANALYSIS
    • 8.18.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL STEM CELL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2 GLOBAL STEM CELLS MARKET BY PRODUCTS 2018-2026 ($ MILLION)
  • TABLE 3 GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 4 GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY TYPES 2018-2026 ($ MILLION)
  • TABLE 5 GLOBAL ADULT STEM CELL MARKET IN HEMATOPOIETIC STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 6 GLOBAL ADULT STEM CELL MARKET IN MESENCHYMAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 7 GLOBAL ADULT STEM CELL MARKET IN NEURAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 8 GLOBAL ADULT STEM CELL MARKET IN DENTAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 9 GLOBAL ADULT STEM CELL MARKET IN UMBILICAL CORD STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 10 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 11 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 12 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 13 GLOBAL STEM CELL MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
  • TABLE 14 GLOBAL STEM CELL MARKET IN ACQUISITION BY TYPES 2018-2026 ($ MILLION)
  • TABLE 15 GLOBAL STEM CELL MARKET IN ACQUISITION BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 16 GLOBAL STEM CELL ACQUISITION MARKET IN BONE MARROW BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 17 GLOBAL STEM CELL ACQUISITION MARKET IN CELL APHERESIS BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 18 GLOBAL STEM CELL ACQUISITION MARKET IN UMBILICAL CORD BLOOD BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 19 GLOBAL STEM CELL MARKET IN PRODUCTION BY TYPES 2018-2026 ($ MILLION)
  • TABLE 20 GLOBAL STEM CELL MARKET IN PRODUCTION BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 21 GLOBAL STEM CELL PRODUCTION MARKET IN THERAPEUTIC CLONING BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 22 GLOBAL STEM CELL PRODUCTION MARKET IN IVF STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 23 GLOBAL STEM CELL PRODUCTION MARKET IN STEM CELL CULTURE BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 24 GLOBAL STEM CELL MARKET IN STEM CELL CRYOPRESERVATION BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 25 GLOBAL STEM CELL MARKET IN STEM CELL EXPANSION AND SUB-CULTURE BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 26 GLOBAL STEM CELLS MARKET BY APPLICATION 2018-2026 ($ MILLION)
  • TABLE 27 GLOBAL STEM CELLS MARKET IN REGENERATIVE MEDICINE BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 28 GLOBAL STEM CELL MARKET IN DRUG DISCOVERY AND DEVELOPMENT BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 29 GLOBAL STEM CELL MARKET BY GEOGRAPHY 2018-2026 (IN $ MILLION)
  • TABLE 30 NORTH AMERICA STEM CELL MARKET, BY COUNTRY, 2018-2026 (IN $ MILLION)
  • TABLE 31 EUROPE STEM CELL MARKET BY COUNTRY 2018-2026 (IN $ MILLION)
  • TABLE 32 ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2018-2026 ($ MILLION)
  • TABLE 33 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES
  • TABLE 34 REST OF WORLD STEM CELL MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • FIGURES LIST
  • FIGURE 1 GLOBAL STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 2 GLOBAL STEM CELL MARKET IN ADULT STEM CELL BY GEOGRAPHY 2018-2026 ($ MILLION)
  • FIGURE 3 GLOBAL ADULT STEM CELL MARKET IN HEMATOPOIETIC STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 4 GLOBAL ADULT STEM CELL MARKET IN MESENCHYMAL STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 5 GLOBAL ADULT STEM CELL MARKET IN NEURAL STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 6 GLOBAL ADULT STEM CELL MARKET IN DENTAL STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 7 GLOBAL ADULT STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 8 GLOBAL STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 9 GLOBAL STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 10 GLOBAL STEM CELL MARKET IN RAT NEURAL STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 11 GLOBAL STEM CELL MARKET IN ACQUISITION 2018-2026 ($ MILLION)
  • FIGURE 12 GLOBAL STEM CELL ACQUISITION MARKET IN BONE MARROW 2018-2026 ($ MILLION)
  • FIGURE 13 GLOBAL STEM CELL ACQUISITION MARKET IN APHERESIS 2018-2026 ($ MILLION)
  • FIGURE 14 GLOBAL STEM CELL ACQUISITION MARKET IN UMBILICAL CORD BLOOD 2018-2026 ($ MILLION)
  • FIGURE 15 GLOBAL STEM CELL MARKET IN PRODUCTION 2018-2026 ($ MILLION)
  • FIGURE 16 GLOBAL STEM CELL PRODUCTION MARKET IN THERAPEUTIC CLONING 2018-2026 ($ MILLION)
  • FIGURE 17 GLOBAL STEM CELL PRODUCTION MARKET IN IVF STEM CELL 2018-2026 ($ MILLION)
  • FIGURE 18 GLOBAL STEM CELL PRODUCTION MARKET IN STEM CELLS CULTURE 2018-2026 ($ MILLION)
  • FIGURE 19 GLOBAL STEM CELL MARKET IN STEM CELLS CRYOPRESERVATION 2018-2026 ($ MILLION)
  • FIGURE 20 GLOBAL STEM CELL MARKET IN STEM CELL EXPANSION AND SUB-CULTURE 2018-2026 ($ MILLION)
  • FIGURE 21 GLOBAL STEM CELLS MARKET IN REGENERATIVE MEDICINE 2018-2026 ($ MILLION)
  • FIGURE 22 GLOBAL STEM CELL MARKET IN DRUG DISCOVERY AND DEVELOPMENT 2018-2026 ($ MILLION)
  • FIGURE 23 THE UNITED STATES STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 24 CANADA STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 25 THE UNITED KINGDOM STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 26 FRANCE STEM CELL MARKET, 2018-2026 (IN $ MILLION)
  • FIGURE 27 GERMANY STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 28 SPAIN STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 29 ITALY STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 30 REST OF EUROPE STEM CELL MARKET 2018-2026 (IN $ MILLION)
  • FIGURE 31 ASIA PACIFIC STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 32 INDIA STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 33 CHINA STEM CELL MARKET 2018-2026($ MILLION)
  • FIGURE 34 JAPAN STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 35 SOUTH KOREA STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 36 REST OF APAC STEM CELL MARKET 2018-2026($ MILLION)
  • FIGURE 37 REST OF WORLD STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 38 LATIN AMERICA STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 39 MIDDLE EAST & AFRICA STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 40 REST OF AFRICA STEM CELL MARKET 2018-2026 ($ MILLION)
  • FIGURE 41 STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2017 (%)
Back to Top